So-called forever chemicals or PFAS compounds are a growing environmental problem. An innovative approach to treating ...
Elekta announced today that its Evo CT Linac received FDA 510(k) clearance, making it available to U.S. radiation oncology ...
In a historic first for the laboratory, CERN has received $1 billion in private ...
Researchers in Japan are developing world-leading expertise in making and using the alpha particle emitter, astatine-211 (211 At), which has potential for use as a strong radionuclide therapy for ...
Exciting electronic characteristics emerge when scientists stack 2D materials on top of each other and give the top layer a ...